Evidence map›Paper›PMID 24966600›Full record

ReviewWorld journal of gastroenterology2014

Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Ikuo Nakamura

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Gut Microbiota: A Novel Player in Autoimmune Hepatitis.Frontiers in cellular and infection microbiology · 2022
    Review
  7. Effects of Inclusion ofAnimals : an open access journal from MDPI · 2021
    Article
  8. Article
  9. Mechanisms of Resistance toFrontiers in microbiology · 2020
    Review
  10. Review
  11. Article
  12. Branched Chain Amino Acids: Beyond Nutrition Metabolism.International journal of molecular sciences · 2018
    Review
  13. Review
  14. Branched-chain amino acids in liver diseases.Translational gastroenterology and hepatology · 2018
    Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ikuo NakamuraIkuo Nakamura, Department of Gastroenterology, Tokyo Medical University, Tokyo 160-0023, Japan.
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been reported that host defense responses, such as phagocytic function of neutrophils and natural killer (NK) cell activity of lymphocytes, are impaired in cirrhotic patients. This review will concentrate on the impairment of innate immune responses in decompensated cirrhotic patients and the effect of the treatment by branched-chain amino acids (BCAA) on innate immune responses. We already reported that phagocytic function of neutrophils was significantly improved by 3-mo BCAA supplementation. In addition, the changes of NK activity were also significant at 3 mo of supplementation compared with before supplementation. Also, Fisher's ratios were reported to be significantly increased at 3 mo of BCAA supplementation compared with those before oral supplementation. Therefore, administration of BCAA could reduce the risk of bacterial and viral infection in patients with decompensated cirrhosis by restoring impaired innate immune responses of the host. In addition, it was also revealed that BCAA oral supplementation could reduce the risk of development of hepatocellular carcinoma in cirrhotic patients. The mechanisms of the effects will also be discussed in this review article.

Indexed as

Dietary SupplementsAdministration, OralAmino Acids, Branched-ChainCarcinoma, HepatocellularHumansImmunity, InnateKiller Cells, NaturalLiver CirrhosisLiver NeoplasmsNeutrophilsPhagocytosisRisk FactorsTreatment OutcomeAmino Acids, Branched-ChainBranched-chain amino acidsInnate immunityLiver cirrhosisNatural killer cell activity of lymphocytesPhagocytic function of neutrophils

Identifiers

PMID24966600
PMCPMC4064075
OpenAlexW1965836260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.